Prenatal yoga offers a wide range of physical and emotional benefits for expecting mothers. By introducing yoga to a healthy ...

Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

Question: I have recently been diagnosed with sciatica and I am finding it difficult to do any exercise. My usual form of ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

Vertex Pharmaceuticals Inc. hit a major milestone on Thursday when the U.S. Food and Drug Administration approved its ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...